Document is current
Any future updates will be listed below
-
Authors
Blau-Schneider, Bettina https://orcid.org/0009-0004-8015-5973
Bilir, Esra
Kiesel, Matthias
Scherer-Quenzer, Anne
Gabriel, Boris
Wöckel, Achim
Pecks, Ulrich
Gasimli, Kayal
Büchel, Johanna
-
Funding
Funding for this research was provided by:
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 17 November 2025
First Online: 16 December 2025
Declarations
:
: Ethical approval for this study was granted by the Institutional 90 Review Board (IRB) of the University Hospital of Wuerzburg (Approval number: 2024–91 280-ka).
: Bettina Blau-Schneider: Honoria and expenses from INTUITIVE Surgical, PFM Medical, MSD, Seagen, all of them not related to this trial.Esra Bilir: Honoria from GSK, not related to this trial.Matthias Kiesel: no conflict of interest.Anne Scherer-Quenzer: no conflict of interest.Boris Gabriel: Honoria and expenses from INTUITIVE Surgical, Serag-Wiessner, all of them not related to this trial.Achim Wöckel: Consulting fees from Amgen, AstraZeneca, Celgene, Lilly, Novartis, Pfizer, Roche, MSD, Genomic Health, Organon, Seagen, Gilead, Dajiichi Sanko, Stemline.Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca, Aurikamed, Celgene, Lilly, Novartis, Pfizer, Roche, MSD, Genomic Health, Seagen, Exact Sciences, Gilead, Dajiichi Sanko, Onkowissen, Stemline, all of them not related to this trial.Ulrich Pecks: no conflict of interest.Kayal Gasimli: no conflict of interest.Johanna Büchel: no conflict of interest.
